Product/Composition:- | Perindopril tablet |
---|---|
Strength:- | 2 mg, 4 mg, 8 mg, and 16 mg |
Form:- | Tablet |
Reference Brands:- | Coversyl, Aceon(EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Perindopril is an ACE inhibitor that blocks the conversion of angiotensin I to angiotensin II, causing vasodilation. It lowers blood pressure, reduces heart workload, and prevents strokes and heart attacks. Benefits include improved cardiovascular health, symptom relief, and long-term protection against heart failure and related complications.
Perindopril tablets, marketed as Coversyl and generic in the EU and US, are approved for hypertension and heart failure management. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access strategies, visit PharmaTradz. Proper adherence to regional regulations supports timely approval, safe use, and global availability of perindopril tablets, helping improve cardiovascular health outcomes worldwide.